Concert Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-6,859
Closed -$221K 103
2017
Q2
$221K Sell
6,859
-60,247
-90% -$1.9M 0.21% 132
2017
Q1
$2.06M Sell
67,106
-6,690
-9% -$211K 0.46% 45
2016
Q4
$2.26M Sell
73,796
-117,544
-61% -$3.59M 0.5% 40
2016
Q3
$6.15M Buy
191,340
+6,202
+3% +$207K 0.75% 20
2016
Q2
$6.19M Buy
185,138
+23,507
+15% +$750K 0.84% 16
2016
Q1
$4.56M Buy
161,631
+1,441
+0.9% +$41.2K 0.61% 27
2015
Q4
$4.9M Sell
160,190
-405
-0.3% -$12.7K 0.65% 28
2015
Q3
$4.78M Buy
160,595
+14,010
+10% +$449K 0.65% 27
2015
Q2
$4.67M Sell
146,585
-8,183
-5% -$267K 0.6% 24
2015
Q1
$3.23M Buy
154,768
+54,252
+54% +$1.72M 0.92% 13
2014
Q4
$2.96M Buy
100,516
+29,141
+41% +$836K 0.45% 40
2014
Q3
$2.01M Sell
71,375
-21,528
-23% -$604K 0.27% 44
2014
Q2
$2.46M Buy
92,903
+208
+0.2% +$5.93K 0.3% 31
2014
Q1
$2.8M Sell
92,695
-6,075
-6% -$181K 0.35% 23
2013
Q4
$2.86M Buy
98,770
+11,589
+13% +$337K 0.37% 21
2013
Q3
$2.37M Buy
87,181
+3,292
+4% +$89.6K 0.34% 24
2013
Q2
$2.23M Buy
+83,889
New +$2.32M 0.33% 24

Other funds holding PFE

Concert Wealth Management's PFE Position: Q3 2017 in Review

Concert Wealth Management sold out of Pfizer (PFE) in Q3 2017, closing a stake of 6,859 shares — an estimated $221K sold.

Concert Wealth Management first reported a position in PFE in Q2 2013 and held it in 17 quarters. The position peaked at $6.19M in Q2 2016. 2,040 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • Concert Wealth Management reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
  • Concert Wealth Management sold 6,859 Pfizer shares in Q3 2017, an estimated $221K.
  • Concert Wealth Management first reported a position in Pfizer in Q2 2013 and held it in 17 quarters.
  • Concert Wealth Management's Pfizer position peaked at $6.19M in Q2 2016.
  • 2,040 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Concert Wealth Management's 13F filing for Q3 2017, filed 14 Nov 2017.